2012 Q1 Form 10-Q Financial Statement

#000110465912034943 Filed on May 09, 2012

View on sec.gov

Income Statement

Concept 2012 Q1 2011 Q4 2011 Q1
Revenue $7.804M $4.200M $3.863M
YoY Change 102.02% 90.91% -19.52%
Cost Of Revenue $6.495M $6.600M $3.667M
YoY Change 77.12% 214.29% -0.89%
Gross Profit $1.309M -$2.400M $196.0K
YoY Change 567.86% -2500.0% -80.4%
Gross Profit Margin 16.77% -57.14% 5.07%
Selling, General & Admin $11.15M $7.200M $3.523M
YoY Change 216.55% 200.0% 252.3%
% of Gross Profit 851.95% 1797.45%
Research & Development $1.294M $2.100M $3.795M
YoY Change -65.9% -43.24% -17.5%
% of Gross Profit 98.85% 1936.22%
Depreciation & Amortization $1.380M $1.280M $990.0K
YoY Change 39.39% 28.0% -3.88%
% of Gross Profit 105.42% 505.1%
Operating Expenses $18.94M $9.400M $10.99M
YoY Change 72.43% 54.1% 92.72%
Operating Profit -$11.14M -$11.80M -$7.122M
YoY Change 56.37% 96.67% 51.53%
Interest Expense $514.0K -$600.0K $2.481M
YoY Change -79.28% -53.85% -513.5%
% of Operating Profit
Other Income/Expense, Net -$757.0K $0.00 -$2.653M
YoY Change -71.47% -100.0% 1226.5%
Pretax Income -$11.90M -$15.30M -$9.800M
YoY Change 21.43% 118.57% 81.48%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$11.89M -$15.30M -$9.775M
YoY Change 21.68% 118.57% 81.02%
Net Earnings / Revenue -152.41% -364.29% -253.04%
Basic Earnings Per Share -$0.47
Diluted Earnings Per Share -$0.47 -$624.5K -$980.0K
COMMON SHARES
Basic Shares Outstanding 25.37M shares 17.23M shares 10.01M shares
Diluted Shares Outstanding 25.37M shares 10.01M shares

Balance Sheet

Concept 2012 Q1 2011 Q4 2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $54.80M $76.20M $59.30M
YoY Change -7.59% 191.95%
Cash & Equivalents $25.21M $46.17M $59.33M
Short-Term Investments $29.60M $30.00M
Other Short-Term Assets $1.500M $3.100M $1.100M
YoY Change 36.36% 47.62%
Inventory $5.078M $1.245M $1.800M
Prepaid Expenses
Receivables $860.0K $2.113M $1.800M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $62.26M $82.65M $64.00M
YoY Change -2.71% 166.14%
LONG-TERM ASSETS
Property, Plant & Equipment $26.49M $25.10M $24.40M
YoY Change 8.57% 4.81%
Goodwill $0.00
YoY Change
Intangibles $4.746M $5.259M
YoY Change -40.99%
Long-Term Investments
YoY Change
Other Assets $762.0K $479.0K $1.100M
YoY Change -30.73% -81.89%
Total Long-Term Assets $32.00M $30.84M $33.90M
YoY Change -5.6% -13.14%
TOTAL ASSETS
Total Short-Term Assets $62.26M $82.65M $64.00M
Total Long-Term Assets $32.00M $30.84M $33.90M
Total Assets $94.26M $113.5M $97.90M
YoY Change -3.71% 70.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.302M $3.440M $6.100M
YoY Change -62.26% -20.28%
Accrued Expenses $7.040M $7.159M $3.800M
YoY Change 85.26% 43.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.364M $7.039M $7.200M
YoY Change -81.06% 121.21%
Total Short-Term Liabilities $19.16M $31.91M $19.70M
YoY Change -2.75% 95.51%
LONG-TERM LIABILITIES
Long-Term Debt $23.63M $18.54M $22.40M
YoY Change 5.5% -15.24%
Other Long-Term Liabilities $2.675M $2.778M $24.60M
YoY Change -89.13% -26.57%
Total Long-Term Liabilities $26.31M $21.32M $47.00M
YoY Change -44.03% -16.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.16M $31.91M $19.70M
Total Long-Term Liabilities $26.31M $21.32M $47.00M
Total Liabilities $57.02M $65.22M $66.70M
YoY Change -14.51% -43.26%
SHAREHOLDERS EQUITY
Retained Earnings -$192.1M -$180.2M
YoY Change 31.65%
Common Stock $25.00K $25.00K
YoY Change 2400.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.000K $2.000K
YoY Change 0.0%
Treasury Stock Shares 1.065K shares 1.065K shares
Shareholders Equity $37.24M $48.27M $31.10M
YoY Change
Total Liabilities & Shareholders Equity $94.26M $113.5M $97.90M
YoY Change -3.71% 70.5%

Cashflow Statement

Concept 2012 Q1 2011 Q4 2011 Q1
OPERATING ACTIVITIES
Net Income -$11.89M -$15.30M -$9.775M
YoY Change 21.68% 118.57% 81.02%
Depreciation, Depletion And Amortization $1.380M $1.280M $990.0K
YoY Change 39.39% 28.0% -3.88%
Cash From Operating Activities -$17.55M -$7.600M -$3.990M
YoY Change 339.85% 30.14% 10.83%
INVESTING ACTIVITIES
Capital Expenditures $2.901M -$2.490M -$830.0K
YoY Change -449.52% -15.59% 97.62%
Acquisitions
YoY Change
Other Investing Activities $370.0K -$9.290M $0.00
YoY Change
Cash From Investing Activities -$2.530M -$11.76M -$830.0K
YoY Change 204.82% 298.64% 97.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $49.00M $37.10M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -880.0K 49.13M 38.02M
YoY Change -102.31% 133.18% 406.93%
NET CHANGE
Cash From Operating Activities -17.55M -7.600M -3.990M
Cash From Investing Activities -2.530M -11.76M -830.0K
Cash From Financing Activities -880.0K 49.13M 38.02M
Net Change In Cash -20.96M 29.77M 33.20M
YoY Change -163.13% 142.43% 854.02%
FREE CASH FLOW
Cash From Operating Activities -$17.55M -$7.600M -$3.990M
Capital Expenditures $2.901M -$2.490M -$830.0K
Free Cash Flow -$20.45M -$5.110M -$3.160M
YoY Change 547.18% 76.82% -0.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
762000 USD
CY2012Q1 us-gaap Assets
Assets
94264000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25103000 USD
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5259000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
479000 USD
CY2011Q4 us-gaap Assets
Assets
113490000 USD
CY2012Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2302000 USD
CY2012Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7040000 USD
CY2012Q1 pcrx Royalty Interest Obligation Current
RoyaltyInterestObligationCurrent
1221000 USD
CY2012Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7231000 USD
CY2012Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1364000 USD
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
19158000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3440000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7159000 USD
CY2011Q4 pcrx Royalty Interest Obligation Current
RoyaltyInterestObligationCurrent
1219000 USD
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13054000 USD
CY2011Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7039000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
31911000 USD
CY2012Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
23632000 USD
CY2012Q1 pcrx Royalty Interest Obligation Noncurrent
RoyaltyInterestObligationNoncurrent
1442000 USD
CY2012Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
8073000 USD
CY2012Q1 pcrx Contingent Purchase Liability
ContingentPurchaseLiability
2042000 USD
CY2012Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2675000 USD
CY2012Q1 us-gaap Liabilities
Liabilities
57022000 USD
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18537000 USD
CY2011Q4 pcrx Royalty Interest Obligation Noncurrent
RoyaltyInterestObligationNoncurrent
1537000 USD
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
8416000 USD
CY2011Q4 pcrx Contingent Purchase Liability
ContingentPurchaseLiability
2042000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2778000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
65221000 USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
25000 USD
CY2012Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
229335000 USD
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-192133000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
17000 USD
CY2012Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2000 USD
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
37242000 USD
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
94264000 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
25000 USD
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
228470000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-180239000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000 USD
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113490000 USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2012Q1 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25340103 shares
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25213000 USD
CY2011Q1 us-gaap Royalty Expense
RoyaltyExpense
311000 USD
CY2011Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10014042 shares
CY2012Q1 us-gaap Inventory Net
InventoryNet
5078000 USD
CY2012Q1 us-gaap Short Term Investments
ShortTermInvestments
29617000 USD
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
860000 USD
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
63000 USD
CY2012Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1496000 USD
CY2012Q1 us-gaap Assets Current
AssetsCurrent
62264000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46168000 USD
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1299000 USD
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
29985000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2113000 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
1245000 USD
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1839000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
82649000 USD
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26492000 USD
CY2012Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4746000 USD
CY2012Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25414231 shares
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25413166 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25339038 shares
CY2012Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1065 shares
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1065 shares
CY2011Q1 pcrx Supply And Royalty Revenue
SupplyAndRoyaltyRevenue
2653000 USD
CY2011Q1 pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
1210000 USD
CY2011Q1 us-gaap Revenues
Revenues
3863000 USD
CY2012Q1 pcrx Supply And Royalty Revenue
SupplyAndRoyaltyRevenue
1314000 USD
CY2012Q1 pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
6490000 USD
CY2012Q1 us-gaap Revenues
Revenues
7804000 USD
CY2011Q1 us-gaap Cost Of Revenue
CostOfRevenue
3667000 USD
CY2012Q1 us-gaap Cost Of Revenue
CostOfRevenue
6495000 USD
CY2011Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3795000 USD
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1294000 USD
CY2011Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3523000 USD
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11152000 USD
CY2011Q1 us-gaap Operating Expenses
OperatingExpenses
10985000 USD
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
18941000 USD
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7122000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11137000 USD
CY2011Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
29000 USD
CY2011Q1 us-gaap Interest Expense
InterestExpense
2481000 USD
CY2012Q1 us-gaap Interest Expense
InterestExpense
514000 USD
CY2012Q1 us-gaap Royalty Expense
RoyaltyExpense
282000 USD
CY2011Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
110000 USD
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24000 USD
CY2011Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2653000 USD
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-757000 USD
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-9775000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-11894000 USD
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.98
CY2012Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-20955000 USD
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000 USD
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1380000 USD
CY2012Q1 pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
-56000 USD
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.47
CY2011Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10014042 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25367306 shares
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25367306 shares
CY2011Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9775000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11892000 USD
CY2012Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
153000 USD
CY2012Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
712000 USD
CY2012Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
103000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
712000 USD
CY2012Q1 pcrx Change In Royalty Interest Obligation
ChangeInRoyaltyInterestObligation
93000 USD
CY2012Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-1299000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1253000 USD
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3833000 USD
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-366000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-613000 USD
CY2012Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3000 USD
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6166000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17545000 USD
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2901000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2530000 USD
CY2012Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
153000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-880000 USD
CY2012Q1 us-gaap Interest Paid
InterestPaid
1168000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26133000 USD
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59331000 USD
CY2012Q1 dei Entity Registrant Name
EntityRegistrantName
Pacira Pharmaceuticals, Inc.
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32315166 shares
CY2012Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001396814
CY2012Q1 dei Document Type
DocumentType
10-Q
CY2012Q1 dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
CY2012Q1 dei Amendment Flag
AmendmentFlag
false
CY2012Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1

Files In Submission

Name View Source Status
0001104659-12-034943-index-headers.html Edgar Link pending
0001104659-12-034943-index.html Edgar Link pending
0001104659-12-034943.txt Edgar Link pending
0001104659-12-034943-xbrl.zip Edgar Link pending
a12-8876_110q.htm Edgar Link pending
a12-8876_1ex10d1.htm Edgar Link pending
a12-8876_1ex10d2.htm Edgar Link pending
a12-8876_1ex10d3.htm Edgar Link pending
a12-8876_1ex10d4.htm Edgar Link pending
a12-8876_1ex31d1.htm Edgar Link pending
a12-8876_1ex31d2.htm Edgar Link pending
a12-8876_1ex32d1.htm Edgar Link pending
a12-8876_1ex32d2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g88761kei001.jpg Edgar Link pending
pcrx-20120331.xml Edgar Link completed
pcrx-20120331.xsd Edgar Link pending
pcrx-20120331_cal.xml Edgar Link unprocessable
pcrx-20120331_def.xml Edgar Link unprocessable
pcrx-20120331_lab.xml Edgar Link unprocessable
pcrx-20120331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending